-
Biotech Winners And Losers From Congress' Latest Funding Bill
Thursday, March 22, 2018 - 11:46am | 422Congress introduced the Consolidated Appropriations Act of 2018 on Wednesday, and the bill contains fewer health care provisions than many traders expected. Still, Height Capital Markets analyst Andrea Harris said on Thursday there are several pharmaceuticals and managed care winners and losers...
-
Omeros Spikes 37% Amid Favorable Medicare Policy In Congressional Spending Bill
Thursday, March 22, 2018 - 8:07am | 300Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company that mostly focuses on developing therapies for the treatment of complement-mediated diseases and disorders of the central nervous system, saw its stock soar nearly 40 percent Thursday morning. What Happened American...